Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Christine Chateau

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annales De Pathologie|April 20, 2004
[Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center]Frédéric Bibeau, Marie-Christine Chateau, Bruno Masson
Frontiers in Immunology|December 22, 2022
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancerFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
Bulletin Du Cancer|September 13, 2011
[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications]William Jacot, Stéphane Pouderoux, Frédéric Bibeau, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
[Vascular hepatic injury following neoadjuvant treatment for a cardial adenocarcinoma]Frédéric Bibeau, David Azria, Marie-Christine Chateau, et al.
Bulletin Du Cancer|June 4, 2005
[Recent data on lobular neoplasia of the breast: the pathologist's opinion]Frédéric Bibeau, Cécile Borrelly, Marie-Christine Chateau, et al.
Virchows Archiv : an International Journal of Pathology|November 17, 2007
Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviourFrédéric Bibeau, Marie-Christine Chateau, Michel Guiu, et al.
Pathology Oncology Research : POR|August 16, 2012
The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analysesFlorence Boissière-Michot, Amélie Denouël, Nathalie Boulle, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Bulletin Du Cancer|August 6, 2014
[Breast surgeon role in the management of high-risk breast lesions]Pierre-Emmanuel Colombo, Anne Vincent-Salomon, Marie-Christine Chateau, et al.
Frontiers in Immunology|December 26, 2024
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological featuresFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annales De Pathologie|April 20, 2004
[Management of non-palpable breast lesions with vacuum-assisted large core needle biopsies (Mammotome). Experience with 560 procedures at the Val d'Aurelle Center]Frédéric Bibeau, Marie-Christine Chateau, Bruno Masson
Frontiers in Immunology|December 22, 2022
Correlation of the TIGIT-PVR immune checkpoint axis with clinicopathological features in triple-negative breast cancerFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
Bulletin Du Cancer|September 13, 2011
[Hormone receptors and HER-2 changes during breast cancer progression: clinical implications]William Jacot, Stéphane Pouderoux, Frédéric Bibeau, et al.
Gastroenterologie Clinique Et Biologique|May 31, 2006
[Vascular hepatic injury following neoadjuvant treatment for a cardial adenocarcinoma]Frédéric Bibeau, David Azria, Marie-Christine Chateau, et al.
Bulletin Du Cancer|June 4, 2005
[Recent data on lobular neoplasia of the breast: the pathologist's opinion]Frédéric Bibeau, Cécile Borrelly, Marie-Christine Chateau, et al.
Virchows Archiv : an International Journal of Pathology|November 17, 2007
Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviourFrédéric Bibeau, Marie-Christine Chateau, Michel Guiu, et al.
Pathology Oncology Research : POR|August 16, 2012
The non-crosslinking fixative RCL2®-CS100 is compatible with both pathology diagnosis and molecular analysesFlorence Boissière-Michot, Amélie Denouël, Nathalie Boulle, et al.
Cancer Medicine|March 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging BiomarkersWilliam Jacot, Marie-Christine Chateau, Simon Thezenas, et al.
Bulletin Du Cancer|August 6, 2014
[Breast surgeon role in the management of high-risk breast lesions]Pierre-Emmanuel Colombo, Anne Vincent-Salomon, Marie-Christine Chateau, et al.
Frontiers in Immunology|December 26, 2024
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological featuresFlorence Boissière-Michot, Marie-Christine Chateau, Simon Thézenas, et al.
Pageof 2